Is 3UE undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 3UE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 3UE (€22) is trading above our estimate of fair value (€18.97)
Significantly Below Fair Value: 3UE is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 3UE?
Key metric: As 3UE is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for 3UE. This is calculated by dividing 3UE's market cap by their current
earnings.
What is 3UE's PE Ratio?
PE Ratio
10.9x
Earnings
US$263.46m
Market Cap
US$2.87b
3UE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: 3UE is good value based on its Price-To-Earnings Ratio (11x) compared to the European Retail REITs industry average (22.5x).
Price to Earnings Ratio vs Fair Ratio
What is 3UE's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
3UE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
10.9x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 3UE's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 3UE forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
€22.00
€21.68
-1.5%
7.8%
€23.82
€19.06
n/a
4
Nov ’25
€20.40
€20.99
+2.9%
7.8%
€23.07
€18.46
n/a
4
Oct ’25
€19.10
€19.93
+4.4%
9.7%
€22.40
€17.02
n/a
4
Sep ’25
€18.90
€19.01
+0.6%
7.6%
€21.14
€17.09
n/a
4
Aug ’25
€18.60
€19.34
+4.0%
8.0%
€21.78
€17.61
n/a
4
Jul ’25
€17.00
€18.38
+8.1%
6.6%
€19.54
€16.75
n/a
4
Jun ’25
€15.70
€18.38
+17.1%
6.6%
€19.54
€16.75
n/a
4
May ’25
€16.00
€18.23
+13.9%
6.6%
€19.38
€16.61
n/a
4
Apr ’25
€16.00
€18.04
+12.7%
6.6%
€19.18
€16.44
n/a
4
Mar ’25
€16.00
€18.04
+12.7%
6.6%
€19.18
€16.44
n/a
4
Feb ’25
€16.00
€18.04
+12.7%
6.6%
€19.18
€16.44
n/a
4
Jan ’25
€14.50
€18.86
+30.1%
12.9%
€22.72
€16.36
n/a
4
Dec ’24
€14.50
€18.43
+27.1%
20.7%
€23.62
€13.23
n/a
4
Nov ’24
€14.50
€18.43
+27.1%
20.7%
€23.62
€13.23
€20.40
4
Oct ’24
€14.50
€18.20
+25.5%
20.1%
€23.04
€12.90
€19.10
4
Sep ’24
€14.50
€18.20
+25.5%
20.1%
€23.04
€12.90
€18.90
4
Aug ’24
€14.60
€17.37
+19.0%
20.7%
€22.27
€12.47
€18.60
4
Jul ’24
€13.70
€17.64
+28.8%
21.5%
€22.91
€12.83
€17.00
4
Jun ’24
€12.00
€17.94
+49.5%
21.5%
€23.31
€13.05
€15.70
4
May ’24
€12.50
€17.55
+40.4%
21.5%
€22.79
€12.76
€16.00
4
Apr ’24
€12.80
€17.87
+39.6%
21.5%
€23.21
€13.00
€16.00
4
Mar ’24
€14.20
€18.25
+28.5%
21.5%
€23.70
€13.27
€16.00
4
Feb ’24
€14.00
€17.85
+27.5%
19.7%
€23.49
€13.15
€16.00
5
Jan ’24
€12.70
€18.07
+42.3%
20.1%
€23.53
€13.18
€14.50
5
Dec ’23
€14.60
€19.37
+32.7%
17.9%
€24.22
€14.53
€14.50
5
Nov ’23
€13.70
€20.07
+46.5%
17.9%
€25.09
€15.05
€14.50
5
Analyst Forecast: Target price is lower than the current share price.